Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

CollPlant Biotechnologies , or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue ...

Xilio Therapeutics announces collaboration with AbbVie for tumor-activated immunotherapies ... 2025 and submitting an investigational new drug application (IND) in the first quarter of 2027.

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections Inspira announced its bio-electronic ...

Juniper Networks, , a leader in secure, AI-Native Networking, today announced new additions to its leading wired access portfolio that enable companies of all sizes to scale their IT operations, ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises ... to get to state where there is more widespread application of them, a more systematic approach ...

The death took place recently in Chicago, USA of Julie Corduff. The deceased was the daughter of Kate and Peter Sheridan RIP, ...

"Risk Factors," of AbbVie's 2023 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its subsequent Quarterly Reports on Form 10-Q.

AbbVie's Rinvoq and Skyrizi could eventually surpass Humira's peak sales. The dividend is well-funded, though an expensive acquisition spree may lead to slower growth. The stock's solid growth ...

AbbVie reported better-than-expected fourth-quarter earnings. Strong demand for the company's Skyrizi and Rinvoq autoimmune therapeutics has helped offset the decline in Humira sales since losing ...